NYU Study finds patients given Hydroxychloroquine + Zinc 44% less likely to die from COVID-19

   

Truth According to Scripture

 

Published on May 14, 2020

Researchers at NYU's Grossman School of Medicine found patients given the antimalarial drug hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus.


  AutoPlay Next Video